Skip to main content

Department of Pharmacology Archives

Study may point to new treatment approach for ASD

Nov. 16, 2017—Using sophisticated genome mining and gene manipulation techniques, researchers at Vanderbilt University Medical Center (VUMC) have solved a mystery that could lead to a new treatment approach for autism spectrum disorder (ASD).

Read more


Meet Vanderbilt’s first Academic Pathways fellows

Oct. 27, 2017—Seven outstanding Ph.D.’s with diverse backgrounds and experiences have come to Vanderbilt to pursue postdoctoral training with an eye toward academic careers.

Read more


New faculty: Erin Calipari, assistant professor of pharmacology

Oct. 23, 2017—Erin Calipari could be described as a code breaker. Using technologies that allow her to probe the activity of single neurons in awake and behaving animals, she is piecing together the neural code that controls motivation and decision-making.

Read more


McGill University honors Roden’s research career

Oct. 19, 2017—Dan Roden, M.D., Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center (VUMC), was named to receive the 2017 Medicine Alumni Global Lifetime Achievement Award by the Faculty of Medicine of his alma mater, McGill University.

Read more


Grant supports Oates’ research on acetaminophen and stroke

Sep. 21, 2017—John Oates, M.D., a pioneering clinical pharmacologist at Vanderbilt University Medical Center (VUMC), has been awarded a one-year, $20,000 grant from the Brain Aneurysm Foundation to support studies of the stroke-reducing potential of acetaminophen.

Read more


University of Kansas honors Lindsley’s pharmacology research

Sep. 21, 2017—Craig Lindsley, Ph.D., co-director of the Vanderbilt Center for Neuroscience Drug Discovery, has been honored by the University of Kansas with the 2018 Edward E. Smissman Lectureship for his outstanding contributions to the fields of medicinal chemistry and molecular pharmacology.

Read more


Goal of new tissue-chip research is to assess efficacy of novel epilepsy drugs

Sep. 20, 2017—An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy.

Read more


Inhibiting obesity

Sep. 15, 2017—An enzyme in the gut – NAPE-PLD – is required for the action of signaling molecules that reduce food intake and weight gain.

Read more


Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.

Read more


Vanderbilt mourns loss of pharmacologist H. Alex Brown

Jul. 26, 2017—H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology at Vanderbilt University School of Medicine, died from cancer Tuesday, July 25, at his home. He was 56.

Read more


NOTCH1 role in heart development

Jul. 3, 2017—The identification of a genetic culprit for hypoplastic left heart syndrome could lead to new treatments for the condition.

Read more


Cytokine linked to blindness

Jun. 30, 2017—A signaling molecule called interleukin-6 may be a therapeutic target to prevent vision loss or nerve degeneration in glaucoma, Vanderbilt researchers have discovered.

Read more


Page 2 of 912345678...Last »

Upcoming Events

MORE EVENTS »